• 1
    Sohar E, Gafni J, Pras M, Heller J. Familial Mediterranean fever: a survey of 470 cases and review of the literature. Am J Med 1967; 43: 22753.
  • 2
    Pras M, Bronshpigel N, Zemer D, Gafni J. Variable incidence of amyloidosis in familial Mediterranean fever among different ethnic groups. Johns Hopkins Med J 1982; 150: 226.
  • 3
    Booth DR, Gillmore JD, Booth SE, Pepys MB, Hawkins PN. Pyrin/marenostrin mutations in familial Mediterranean fever. QJM 1998; 91: 6036.
  • 4
    Bernot A, da Silva C, Petit JL, Cruaud C, Caloustian C, Castet V, et al. Non-founder mutations in the MEFV gene establish this gene as the cause of familial Mediterranean fever. Hum Mol Genet 1998; 7: 131725.
  • 5
    Aksentijevich I, Torosyan Y, Samuels J, Centola M, Pras E, Chae JJ, et al. Mutation and haplotype studies of familial Mediterranean fever reveal new ancestral relationships and evidence for a high carrier frequency in the Ashkenazi Jewish population. Am J Hum Genet 1999; 64: 94962.
  • 6
    Gershoni-Baruch R, Shinawi M, Kasinetz L, Badarna K, Brik R. Familial Mediterranean fever: prevalence, penetrance and genetic drift. Eur J Hum Genet 2001; 9: 6347.
  • 7
    Shinawi M, Brik R, Berant M, Kasinetz L, Gershoni-Baruch R. Familial Mediterranean fever: high gene frequency and heterogeneous disease among an Israeli-Arab population. J Rheumatol 2000; 27: 14925.
  • 8
    Dewalle M, Domingo C, Rozenbaum M, Ben-Chetrit E, Cattan D, Bernot A, et al. Phenotype-genotype correlation in Jewish patients suffering from familial Mediterranean fever (FMF). Eur J Hum Genet 1998; 6: 957.
  • 9
    Cazeneuve C, Sarkisian T, Pecheux C, Dervichian M, Nedelec B, Reinert P, et al. MEFV-gene analysis in Armenian patients with familial Mediterranean fever: diagnostic value and unfavourable renal prognosis of the M694V homozygous genotype-genetic and therapeutic implications. Am J Hum Genet 1999; 65: 8897.
  • 10
    Shohat M, Magal N, Shohat T, Chen X, Dagan T, Mimouni A, et al. Phenotype-genotype correlation in familial Mediterranean fever: evidence for an association between Met694Val and amyloidosis. Eur J Hum Genet 1999; 7: 28792.
  • 11
    Livneh A, Langevitz P, Shinar Y, Zaks N, Kastner DL, Pras M, et al. MEFV mutation analysis of patients suffering from amyloidosis in familial Mediterranean fever. Amyloid 1999; 6: 16.
  • 12
    Brik R, Shinawi M, Kepten I, Berant M, Gershoni-Baruch R. Familial Mediterranean fever: clinical and genetic characterization in a mixed pediatric population of Jewish and Arab patients. Pediatrics 1999; 103: e70.
  • 13
    Shinar Y, Livneh A, Langevitz P, Zaks N, Aksentijevich I, Koziol E, et al. Phenotype-genotype assessment of common genotypes among patients with familial Mediterranean fever. J Rheumatol 2000; 27: 17037.
  • 14
    Gershoni-Baruch R, Brik R, Shinawi M, Livneh A. The differential contribution of MEFV mutant alleles to the clinical profile of familial Mediterranean fever. Eur J Hum Genet 2002; 10: 1459.
  • 15
    Stoffman N, Magal N, Shohat T, Lotan R, Koman S, Oron A, et al. Higher than expected carrier rates for familial Mediterranean fever in various Jewish ethnic groups. Eur J Hum Genet 2000; 8: 30710.
  • 16
    Kogan A, Shinar Y, Lidar M, Revivo A, Langevitz P, Padeh S, et al. Common MEFV mutations among Jewish ethnic groups in Israel: high frequency of carrier and phenotype III states and absence of a perceptible biological advantage for the carrier state. Am J Med Genet 2001; 102: 2726.
  • 17
    Zemer D, Pras M, Sohar E, Modan M, Cabili S, Gafni J. Colchicine in the prevention and treatment of the amyloidosis of familial Mediterranean fever. N Engl J Med 1986; 314: 10015.
  • 18
    Yalcinkaya F, Akar N, Misirlioglu M. Familial Mediterranean fever: amyloidosis and the Val726Ala mutation [letter]. N Engl J Med 1998; 338: 9934.
  • 19
    Livneh A, Langevitz P, Zemer D, Padeh S, Migdal A, Sohar E, et al. The changing face of familial Mediterranean fever. Semin Arthritis Rheum 1996; 26: 61227.
  • 20
    Cazeneuve C, Ajrapetyan H, Papin S, Roudot-Thoraval F, Genevieve D, Mudjoyan E, et al. Identification of MEFV-independent genetic factors for familial Mediterranean fever. Am J Hum Genet 2000; 67: 113643.
  • 21
    Liepnicks J, Kluve-Beckerman B, Benson M. Characterization of amyloid A protein in secondary amyloidosis: the predominant deposition of serum amyloid A1. Biochim Biophys Acta 1995; 1270: 816.
  • 22
    Baba S, Masago SA, Takahashi T, Kasama T, Sugimura H, Tsugune S, et al. A novel allelic variant of serum amyloid A, SAA1γ: genomic evidence, evolution, frequency, and implication as a risk factor for reactive systemic AA-amyloidosis. Hum Mol Genet 1995; 4: 10837.
  • 23
    Moriguchi M, Terai C, Koseki Y, Uesato M, Nakajima A, Inada S, et al. Influence of genotypes at the SAA1 and SAA2 loci on the development and length of latent period of secondary AA amyloidosis in patients with rheumatoid arthritis. Hum Genet 1999; 105: 3606.
  • 24
    Moriguchi M, Terai C, Koseki Y, Kaneko H, Uesato M, Nishikawa T, et al. Genotypes at the SAA1 locus correlate with the clinical severity of AA amyloidosis. Amyloid 2001; 8: 11520.
  • 25
    Booth D, Booth S, Gillmore J, Hawkins P, Pepys M. SAA1 alleles as risk factors in reactive systemic AA amyloidosis. Amyloid 1998; 5: 2625.
  • 26
    Moriguchi M, Terai C, Kaneko H, Koseki Y, Kajiyama H, Uesato M, et al. A novel single-nucleotide polymorphism at the 5′-flanking region of SAA1 associated with risk of type AA amyloidosis secondary to rheumatoid arthritis. Arthritis Rheum 2001; 44: 126672.
  • 27
    Livneh A, Langevitz P, Zemer D, Zaks N, Kees S, Lidar T, et al. Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum 1997; 40: 187985.
  • 28
    Pras E, Livneh A, Balow JE Jr, Pras E, Kastner DL, Pras M, et al. Clinical differences between North African and Iraqi Jews with familial Mediterranean fever. Am J Med Genet 1998; 75: 2169.
  • 29
    Gershoni-Baruch R, Kepten I, Shinawi M, Brik R. Direct detection of common mutations in familial mediterranean fever gene (MEFV) using naturally occurring and primer mediated restriction fragment analysis. Hum Mutation in brief 1999; 257 (online).
  • 30
    Gershoni-Baruch R, Brik R, Shinawi M, Lidar M, Livneh A. Male gender coupled with articular manifestations cause a fourfold increase in susceptibility to amyloidosis in FMF patients homozygous for the M694V-MEFV mutation. J Rheumatol 2003; 30: 30812.
  • 31
    Touitou I, Picot MC, Domingo C, Notarnicola C, Cattan D, Demaille J, et al. The MICA region determines the first modifier locus in familial Mediterranean fever. Arthritis Rheum 2001; 44: 1639.
  • 32
    De Berr FC, Mallya RK, Fagan EA, Lanham JG, Hughes GR, Pepys MB. Serum amyloid A protein concentration in inflammatory diseases and its relationship to the incidence of reactive systemic amyloidosis. Lancet 1982; 2: 2314.
  • 33
    Maury CP, Wegelius O. Clinical value of serum amyloid A and C-reactive protein measurements in secondary amyloidosis. Int J Tissue React 1985; 7: 4057.